EE367 Cost-Effectiveness Analysis of Upadacitinib As a Treatment Option for Patients with Rheumatoid Arthritis in Kingdom of Saudi Arabia
Jul 1, 2022, 00:00 AM
10.1016/j.jval.2022.04.615
https://www.valueinhealthjournal.com/article/S1098-3015(22)00816-6/fulltext
Section Title :
Section Order :
10552
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00816-6&doi=10.1016/j.jval.2022.04.615